Surgical interventional strategies for the treatment of obesity are being implemented at an increasing rate. The safety and feasibility of these procedures are questionable for most overweight or obese individuals. The use of long-term pharmacotherapy options, on the other hand, can target a greater portion of the obese population and provide early intervention to help individuals maintain a he...

background: obesity is pandemic worldwide and a strong risk factor for cardio-metabolic disorders. the few approved anti-obesity drugs have poor efficacy and safety profile. thus, there is an urgent need for new anti-obesity agents. according to the traditional medicine and a clinical trial, saffron may have anorexigenic and anti-obesity effects which need further investigation. objectives: eva...

Methanolic extracts of Bauhinia purpurea (MEBP) were evaluated for their antilipidemic and antiobesity efficacy in high fat diet (HFD) induced male wistar albino obese rats. The body weight of HFD induced obese rats was reduced by 30 % when administered with sibutramine (standard antiobesity drug), while it was reduced by 24 % and 28 % respectively by 200 mg and 400 mg of MEBP/kg body weight. W...

Because of the increasing prevalence of obesity, prevention and treatment of overweight has become a major public health concern. In addition to diet and exercise, drugs are needed for patients who failed to lose weight with behavioral treatment. The current article aimed to summarize recent concerns on the safety and efficacy of appetite suppressants. Several appetite suppressants have been ba...

Introduction . Eating disorders (ED) in obese patients dramatically reduce adherence to treatment and its effectiveness, which determines the importance of correcting ED. Aim To evaluate presence various types eating behavior (EB) patients, effect sibutramine liraglutide on EB, hunger satiety optimize individual choice. Materials methods The study included 53 (BMI over 30 kg/m2), whom 17 receiv...